CHTR
Charter Communications, Inc.
CHTR trails on the overall score without a compensating advantage in the available component scores.
TMUS
T-Mobile US, Inc.
TMUS has the edge over CHTR overall, supported by stronger modeled upside and lower modeled downside.
CHTR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Weak |
CHTR's revenue, profitability and cash flow are currently stable, but its balance sheet is weak.
TMUS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
TMUS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
CHTR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.1x | $133 | — |
| Cheap | 7.3x | $69.62 | -48% |
| Fair | 12x | $118 | -11% |
| Current | 14x | $133 | — |
| Expensive | 42x | $404 | +205% |
Historical ranges are pointers, not guarantees.
CHTR's PE is in its fair range at 14x. If earnings grow as analysts expect, today's price would be 3.1x next year's earnings, in its cheap range.
TMUS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $171 | — |
| Current | 16x | $171 | — |
| Cheap | 21x | $218 | +27% |
| Fair | 26x | $274 | +60% |
| Expensive | 56x | $581 | +240% |
Historical ranges are pointers, not guarantees.
TMUS has the edge over CHTR in the historical PE scenario, which offers more potential upside but is not a forecast.
CHTR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CHTR, but weaker profitability. However, they disagree widely on these estimates.
TMUS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
TMUS has the edge over CHTR on the outlook, with more favorable profitability expectations.
CHTR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $42.65 | +344% |
| Q3 2026 | $9.60 | -73% |
| Q2 2026 | $38.44 | +5.2% |
| Q1 2026 | $36.96 | +3.1% |
| Q4 2025 | $36.21 | +3.5% |
| Q3 2025 | $36.05 | +13% |
| Q2 2025 | $36.53 | +17% |
| Q1 2025 | $35.84 | +16% |
| Q4 2024 | $34.97 | +17% |
CHTR earned $9.60 per share over the past year, down 73% from the year before.
TMUS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.49 | +30% |
| Q3 2026 | $10.37 | -0.2% |
| Q2 2026 | $9.56 | -9.7% |
| Q1 2026 | $9.41 | -8.1% |
| Q4 2025 | $9.72 | +0.6% |
| Q3 2025 | $10.39 | +18% |
| Q2 2025 | $10.59 | +33% |
| Q1 2025 | $10.24 | +39% |
| Q4 2024 | $9.66 | +39% |
TMUS earned $10.37 per share over the past year, about the same as the year before.
CHTR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $14.9B | +9.1% |
| Q2 2026 | $13.5B | -1.7% |
| Q1 2026 | $13.6B | -1% |
| Q4 2025 | $13.6B | -2.3% |
| Q3 2025 | $13.7B | -0.9% |
| Q2 2025 | $13.8B | +0.6% |
| Q1 2025 | $13.7B | +0.4% |
| Q4 2024 | $13.9B | +1.6% |
CHTR's revenue grew through 2021 and has held roughly level since: $14.9B last quarter, up 9.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -24% | -47 points |
| Q2 2026 | 23% | -1.2 points |
| Q1 2026 | 24% | 0 points |
| Q4 2025 | 24% | -0.4 points |
| Q3 2025 | 23% | -1.3 points |
| Q2 2025 | 24% | 0 points |
| Q1 2025 | 24% | +0.7 points |
| Q4 2024 | 24% | +0.5 points |
CHTR's operating margin was −24% last quarter, down 47 points from the same quarter a year ago, near the bottom of its range since 2019.
TMUS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $23.6B | +7.4% |
| Q2 2026 | $22.8B | +7.9% |
| Q1 2026 | $23.1B | +11% |
| Q4 2025 | $24.3B | +11% |
| Q3 2025 | $22B | +8.9% |
| Q2 2025 | $21.1B | +6.9% |
| Q1 2025 | $20.9B | +6.6% |
| Q4 2024 | $21.9B | +6.8% |
TMUS has the edge over CHTR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 24% | +3.4 points |
| Q2 2026 | 24% | -0.6 points |
| Q1 2026 | 19% | -3.5 points |
| Q4 2025 | 15% | -5.6 points |
| Q3 2025 | 21% | -3.2 points |
| Q2 2025 | 25% | +1.3 points |
| Q1 2025 | 23% | +2.6 points |
| Q4 2024 | 21% | +4 points |
TMUS has the edge over CHTR on profitability, with a higher operating margin.
CHTR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1B | -30% |
| Q2 2026 | $1.1B | +45% |
| Q1 2026 | $1.4B | -21% |
| Q4 2025 | $426M | +7% |
| Q3 2025 | $1.4B | +6.5% |
| Q2 2025 | $726M | -27% |
| Q1 2025 | $1.8B | +336% |
| Q4 2024 | $398M | -60% |
CHTR's free cash flow has been positive every quarter for seven years: $3.9B over the past year, down 11% from the year before.
TMUS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +5.3% |
| Q2 2026 | $4.8B | +4.4% |
| Q1 2026 | $4.6B | +4.6% |
| Q4 2025 | $4.2B | +25% |
| Q3 2025 | $4.8B | +15% |
| Q2 2025 | $4.6B | +32% |
| Q1 2025 | $4.4B | +79% |
| Q4 2024 | $3.3B | +2% |
TMUS has the edge over CHTR on cash flow, with more consistent year-over-year improvement.
CHTR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.6% | -4.3M shares |
| 1 year | -14% | -19.5M shares |
| 3 years | -23% | -35.1M shares |
| 5 years | -38% | -70.2M shares |
| Available history | -46% | -101M shares |
CHTR has the edge over TMUS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $21M |
| Q2 2026 | $852M |
| Q1 2026 | $1B |
| Q4 2025 | $766M |
| Q3 2025 | $2.1B |
| Q2 2025 | $1.5B |
| Q1 2025 | $802M |
| Q4 2024 | $114M |
CHTR spent $2.7B buying back its own shares over the past year, down 41% from the year before.
TMUS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -10.8M shares |
| 1 year | -4.9% | -55M shares |
| 3 years | -8.8% | -103M shares |
| 5 years | -15% | -182M shares |
| Available history | +24% | +207M shares |
TMUS has 1.1B diluted shares, down 4.9% from a year ago, with $12B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.4B |
| Q2 2026 | $2.3B |
| Q1 2026 | $4.8B |
| Q4 2025 | $2.4B |
| Q3 2025 | $2.5B |
| Q2 2025 | $2.6B |
| Q1 2025 | $2.5B |
| Q4 2024 | $4.7B |
TMUS spent $12B buying back its own shares over the past year, down 1.7% from the year before.
CHTR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.0x | High |
| Q2 2026 | 4.4x | High |
| Q1 2026 | 4.3x | High |
| Q4 2025 | 4.4x | High |
| Q3 2025 | 4.4x | High |
| Q2 2025 | 4.3x | High |
| Q1 2025 | 4.3x | High |
| Q4 2024 | 4.3x | High |
CHTR's net debt is about 7.0 years of its operating earnings (EBITDA), up from 4.4 years a year ago.
TMUS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.0x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | 2.5x | Moderate |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 2.4x | Moderate |
TMUS has the edge over CHTR on leverage, with a lower net debt burden relative to earnings.
CHTR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.5 | Neutral |
| Stochastic | 32.9 | Neutral |
CHTR's weekly RSI is 47 (neutral) and its Stochastic is 33 (neutral).
TMUS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.9 | Neutral |
| Stochastic | 42.1 | Neutral |
TMUS's weekly RSI is 48 (neutral) and its Stochastic is 42 (neutral).
CHTR PE vs Communication Services Sector
| Metric | CHTR | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 16x | 16% below |
| PE % | 57 | 26 | 31 pts above |
CHTR has the edge over TMUS on valuation relative to its sector.
TMUS PE vs Communication Services Sector
| Metric | TMUS | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 16x | Same PE |
| PE % | 1 | 26 | 25 pts below |
TMUS is trading at 16x earnings, in line with the Communication Services sector's median of 16x.
CHTR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $113.3 | 17% above |
| 20 week MA | $130.5 | 1.6% above |
| 50 week MA | $168.2 | 21% below |
| 100 week MA | $247.3 | 46% below |
| 200 week MA | $300.4 | 56% below |
CHTR has the edge over TMUS on trend strength, trading above more of its moving averages.
TMUS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $159.1 | 7.5% above |
| 20 week MA | $172.0 | 0.5% below |
| 50 week MA | $187.8 | 8.9% below |
| 100 week MA | $212.9 | 20% below |
| 200 week MA | $188.7 | 9.4% below |
TMUS has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 9.4% below its 200-week average.
CHTR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $483.7 | $656.5 | +36% |
| 2021 | $656.5 | $648.3 | -1.2% |
| 2022 | $648.3 | $333.9 | -48% |
| 2023 | $333.9 | $388.7 | +16% |
| 2024 | $388.7 | $348.7 | -10% |
| 2025 | $348.7 | $207.2 | -41% |
| 2026 YTD | $207.2 | $132.7 | -36% |
CHTR has finished lower in four of the last six years. It's down 36% so far in 2026.
TMUS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $77.2 | $132.9 | +72% |
| 2021 | $132.9 | $119.9 | -9.8% |
| 2022 | $119.9 | $140.0 | +17% |
| 2023 | $140.0 | $160.3 | +15% |
| 2024 | $160.3 | $223.0 | +39% |
| 2025 | $223.0 | $201.0 | -9.9% |
| 2026 YTD | $201.0 | $171.0 | -15% |
TMUS has the edge over CHTR on returns for 2026, with the stronger performance.